SEC

In connection with the engagement of Canaccord Financial (Canaccord) by the Special Committee of the Board of Directors of Dragon Pharmaceutical Inc. (the Exhibit 16(c)(2) - SEC.govIn 1995, he created the fine chemicals company Sylachim S.A., a 100% subsidiary of Synthelabo, active in chemical intermediates and API's for the world's largest

    Leava a Message: